Vol. 2 No. 4 (2025), Articles
Vol. 2 No. 4 (2025)

PRESCRIPTIONS AND DRUGS

Articles
Published 2025-02-27
Asatullayev Rustamjon Baxtiyarovich
Scientific supervisor
Umirzaqova Yasmina Botirovna
Student:
Abdurafikova Shaxrizoda Shuxratovna
Student
PDF

Keywords

medications, healthcare, disease management, chronic illnesses, acute illnesses, antibiotics, antiviral drugs, prevention of complications, vaccines, statins, blood thinners, quality of life, pain relief, psychiatric medications, functionality enhancement.

Abstract

Prescription drugs are an integral part of modern healthcare, essential for treating acute and chronic illnesses, preventing disease progression, and improving quality of life. This article explores the historical evolution of prescription medications, from traditional remedies to advanced pharmaceuticals, highlighting key developments such as the antibiotic revolution and the rise of synthetic drugs. It also examines the regulatory frameworks that ensure drug safety and efficacy, including the role of agencies like the FDA and EMA. Various therapeutic classes of prescription drugs are discussed, along with emerging treatments such as biologics, gene therapies, and immunotherapies. While prescription medications offer numerous benefits, including precision medicine and improved patient outcomes, they also pose challenges such as side effects, drug interactions, misuse, and accessibility barriers. Advances in pharmacogenomics, digital health, and artificial intelligence continue to shape the future of prescription medications, balancing innovation with safety. By understanding the complexities of prescription drugs, healthcare professionals and policymakers can enhance drug efficacy, ensure equitable access, and promote responsible usage in an evolving medical landscape.  

PDF

References

1. Rang, H. P., Ritter, J. M., Flower, R. J., & Henderson, G. (2015). Rang & Dale's Pharmacology (8th ed.). Elsevier.

2. Goodman, L. S., Brunton, L. L., Knollmann, B. C., & Hilal-Dandan, R. (2017). Goodman & Gilman’s: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.

3. Katzung, B. G. (2018). Basic and Clinical Pharmacology (14th ed.). McGraw-Hill Education.

4. Kesselheim, A. S., Avorn, J., & Sarpatwari, A. (2016). "The high cost of prescription drugs in the United States: Origins and prospects for reform." JAMA, 316(8), 858-871. https://doi.org/10.1001/jama.2016.11237

5. Ventola, C. L. (2015). "The pharmaceutical industry and the patent system: Balancing innovation and access." Pharmacy and Therapeutics, 40(4), 277-283.

6. Lemberger, L. (2012). "The role of pharmacogenomics in personalized medicine." Annual Review of Medicine, 63, 195-206.

7. U.S. Food and Drug Administration (FDA). (2023). Drug Approval Process Overview. Retrieved from https://www.fda.gov/drugs/development-approval-process-drugs

8. European Medicines Agency (EMA). (2022). Regulatory Science Strategy to 2025. Retrieved from https://www.ema.europa.eu

9. World Health Organization (WHO). (2021). Access to Essential Medicines: Policies and Regulations. Retrieved from https://www.who.int/medicines

10. Mayo Clinic. (2023). Understanding Prescription Drugs: Benefits and Risks. Retrieved from https://www.mayoclinic.org

11. National Institutes of Health (NIH). (2023). Drug Development and Innovation. Retrieved from https://www.nih.gov